Go back

Qdossier Qsauri
"B"

brief summary
Guideline or reference source
FDA www.fda.gov
Definition
This is the technical name for the detailed information that appears in ads for prescription drugs. The law requires that print ads making claims about a drug (product claim ads) include a "brief summary" with all the risks listed in the drug's "prescribing information" and at least one FDA-approved use of the drug. The brief summary generally includes:   Who should not take the drug; When the drug should not be taken; Possible serious side effects of the drug and, if known, what can be done to lower the chance of having them; Frequently occurring, but not necessarily serious, side effects.   The "brief summary" includes a lot of information, so it is usually presented on its own page of a print ad. When the "brief summary" is part of an ad directed at the consumer, the FDA encourages drug companies to use language consumers can easily understand.  

Send comments to info@qdossier.com Please read disclaimer before using Qsauri.